This topic contains a solution. Click here to go to the answer

Author Question: Why would a chain-reaction control substance that loses neutron-absorbing power as its temperature ... (Read 63 times)

123654777

  • Hero Member
  • *****
  • Posts: 585
Why would a chain-reaction control substance that loses neutron-absorbing power as its temperature increases be dangerous?
 
  A) Because it would start to emit protons.
  B) Neutrons would start to collide with each other and that would be bad.
  C) It would be unusually radioactive.
  D) Unhindered neutrons would cause a meltdown.

Question 2

Which of the following is the most significant environmental advantage of deriving energy from nuclear fission?
 
  A) There are almost no atmospheric pollutants.
  B) Nuclear bombs can be made from fuel by-products.
  C) Waters surrounding each nuclear power plant are warmed.
  D) The uranium fuel supply is virtually unlimited.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

paavo

  • Sr. Member
  • ****
  • Posts: 301
Answer to Question 1

D

Answer to Question 2

A




123654777

  • Member
  • Posts: 585
Reply 2 on: Aug 27, 2018
Wow, this really help


ASDFGJLO

  • Member
  • Posts: 335
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Atropine was named after the Greek goddess Atropos, the oldest and ugliest of the three sisters known as the Fates, who controlled the destiny of men.

Did you know?

Vaccines cause herd immunity. If the majority of people in a community have been vaccinated against a disease, an unvaccinated person is less likely to get the disease since others are less likely to become sick from it and spread the disease.

Did you know?

The types of cancer that alpha interferons are used to treat include hairy cell leukemia, melanoma, follicular non-Hodgkin's lymphoma, and AIDS-related Kaposi's sarcoma.

Did you know?

The average office desk has 400 times more bacteria on it than a toilet.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

For a complete list of videos, visit our video library